⌘+K

Sweden

Healthcare

Elicera Therapeutics

Latest share price

SEK

2.5

1.02%

20 Nov 2026 17:24 CET

Fair value range

SEK

6.0

—

10.0

3 Jul 2026

Market cap

SEK

165

m

Next report

Q3

27 Nov 2026

Elicera Therapeutics

Healthcare

2026-10-12

Phase I part of the CARMA trial now completed

Elicera has now completed the Phase I dose-escalation part of CARMA, with results continuing to support the clinical potential of ELC-301 in heavily pre-treated B-cell...

News

Maria Karlsson Osipova

Phase I part of the CARMA trial now completed

Financed for next clinical steps - Q2 review

New CEO announced

Elicera Therapeutics

Healthcare

2026-08-28

Financed for next clinical steps - Q2 review

Elicera’s Q2 focused on strengthening its financing position and advancing ELC-301 and ELC-401. Operating expenses came to SEK6m (fairly in line with Q2 2025), while the...

Post-Results Note

Maria Karlsson Osipova

Phase I part of the CARMA trial now completed

Financed for next clinical steps - Q2 review

New CEO announced

Elicera Therapeutics

Healthcare

2026-08-18

New CEO announced

Elicera has appointed Johan Liwing as its new CEO, effective 1 September. The recruitment follows the company’s announcement on 24 July that management and headquarters...

News

Maria Karlsson Osipova

Phase I part of the CARMA trial now completed

Financed for next clinical steps - Q2 review

New CEO announced

Price chart

Price

Fair range high value

Fair range low value

Year

2024

2025

2026e

2027e

2028e

EPS

-0.59

-0.42

-0.43

-0.61

0.45

EPS (Adj.)

-0.59

-0.42

-0.43

-0.61

0.45

Sales Growth

EPS Growth (Adj.)

P/E

5.4

P/E (Adj.)

5.4

EV/EBITA

-3.5

-5.3

-4.6

-3.8

4.5

EV/EBITDA

-3.5

-5.3

-4.6

-3.8

4.5

Learn more

Key facts

Sector

Healthcare

Country

Sweden

Tickers

ELIC@SS, ELIC.ST

CEO

Johan Liwing

CFO

Ingvar Karlsson

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB